Viedoc Technologies AB is a comprehensive cloud-based platform built to improve the efficiency of conducting all clinical trials. Since 2003 Viedoc Technologies AB has been used in over 3 000 trials in more than 75 countries in all therapeutic areas and clinical phases.
Created by industry professionals with decades of experience, Viedoc Technologies AB blends innovation with design to simplify your workday. Our mission is to be at the forefront of eClinical innovation by developing new, smarter ways to help all our clients succeed. Viedoc Technologies AB meets all applicable regulatory standards, including ICH GCP, 21 CFR part 11, HIPAA.
Viedoc Technologies AB has offices around the world. With its headquarters in Uppsala, Sweden also has offices in Philadelphia, Tokyo and Shanghai as well as salesforce spread out in many countries throughout Europe.
For more information about Viedoc Technologies, visit: www.viedoc.com
Anju Software Inc. is a healthcare technology company that provides web-based electronic data capture and eClinical solutions and related value-added services to pharmaceutical and biotech companies, contract research organizations and other clinical trial sponsors principally located in the United States, Europe and East Asia.
Anju Software’s proprietary EDC and eClinical software applications – TrialMaster®, TrialOne®, eClinical Suite, Promasys®, IRTMaster, AutoEncoder and Acuity – allow clinical trial sponsors and investigative sites to securely collect, validate, transmit and analyze clinical trial data.
Anju Software Inc. is headquartered in Fort Lauderdale, FL. Anju Software, Inc. is a leading provider of comprehensive software solutions to the life sciences industry that provides an integrated platform spanning clinical operations, medical affairs and commercial divisions, including integrated data intelligence. Anju is a privately owned, Abry Partners portfolio company.
For more information about Anju Software, visit: www.anjusoftware.com.
Biopharma Excellence provides targeted drug development and regulatory consultancy for biopharmaceutical products with the focus to create sustained value.
We prepare tailor-made integrated development plans considering all technical product aspects as well as all regulatory requirements – everything that you need for streamlined development and commercialization.
Our team consists of renowned experts with both agency and industry background.
We have a strong track record in successful conduct of scientific advice meetings as well as the preparation of important regulatory submissions.
Biopharma Excellence is at your disposal to identify the best solutions for you. For further details, please visit us at:
MyData-TRUST supports the Life Sciences Industry in leveraging Data Protection compliance.
Unique combination of IT, Legal and Clinical experts providing a full coverage of services dedicated to Life Sciences with strong Data Protection expertise: consulting, implementation and solution for GDPR, HIPAA and Privacy Shield.
The aim of MyData-TRUST consists in providing strategic, operational and organizational support, making an important contribution both legally and technically to the success of the Data Protection implementation and the company as a whole.
cddi is an international biotechnology and pharmaceutical consulting company, offering a full range of services from product development through to regulatory approval.
We are a structured company, run by senior Industry professionals, and partners with whom we have worked extensively, ensuring commitment, continuity and delivery of objectives.
We have a proven track record in reducing time lines cost effectively.
cddi has been founded by senior executives with many years of experience in the biotechnology and pharmaceutical companies such as Glaxo, Pfizer, Novartis, Pharmacia and Hoechst.
Founded in 1993, EBD Group is an international life science consultancy with offices in California, Munich and the UK, providing Business Development and Drug Development services to pharmaceutical, biotechnology and medical device companies.
EBD’s consultants have strong pharmaceutical and biotechnology backgrounds, and the Group’s services have helped numerous US and European life science companies form a productive bridge between the two continents.
Drug Development - from Clinical to Phase IV
Bio-Pharmaceutical Development: Strategic Clinical Plans - Labeling practices - Pharmacovigilance - Regulatory Consultations - Interactions with FDA and other Regulatory Authorities - Selection of contract research organizations (CROs) - Regulatory Documents (IND, NDA) and Protocol and Report Preparation
FHR Consult offers a diversified range of expert and hands-on consulting support for biotech, VC and pharmaceutical companies in the areas of partnering, licencing, strategy, management, financing and competitive intelligence.
The focus is centered particularly on all aspects of research, development and commercialization of biologicals such as antibodies and other targeted medicines.
We work with an international network of partners and experts to give you the broad coverage, quality advice and tangible support you need for risk-balanced, fast decision-making in complex corporate processes.
Our mission is life-science consulting to make your vision possible.
FGK Pharmacovigilance GmbH (FGK PV) is a growing offspring of FGK Clinical Research GmbH. FGK PV is run by seasoned experts, who are bringing with them knowledge of authorities on both sides of the Atlantic, time-proven safety experience and a steady hand. FGK PV offers:
FGK Representative Service GmbH acts as a legal representative for pharmaceutical and biotechnology companies which have no subsidiary within the EU and which submit regulatory applications to the European authorities.
The Clinical Trials Directive (2001/20/EC), implemented May 1, 2004, requires that a legal representative of the sponsor be established in the EU for all clinical trials conducted in the EU. This is why it is no longer possible for a company outside the EU to conduct a clinical study without an entity representing them in the EU.
Directive 2001/83/EC requires that for a marketing authorization application in the EU the applicant has to be established in the EU.
Regulation (EC) No 141/2000 requires that the sponsor seeking to obtain or
having obtained the designation of a medicinal product as an orphan medicinal
product from the EMEA must be established in the EU.
The Dragon Consulting Group comprises medical device industry experts with more than twenty five years experience in the field of clinical study management. Through affiliations with practicing physicians the Dragon Consulting Group can provide world class expertise in clinical study endpoint management. A network of technical and strategic experts develop clinical and regulatory strategy and provide world class clinical study management through first into man and early stage studies to post approval studies in Europe and the United States. Unlike other major Clinical Research Organizations, the Dragon Consulting Group is structured in a way that allows to offer a broad range of development resources without the high overhead often seen with others.